|
CBWD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.28910004892901E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.7795000029075E-08 |
| Normal-vs-Stage2 |
2.51699999997967E-06 |
| Normal-vs-Stage3 |
2.973600E-04 |
| Normal-vs-Stage4 |
5.829600E-04 |
| Stage1-vs-Stage2 |
5.015000E-01 |
| Stage1-vs-Stage3 |
6.206200E-01 |
| Stage1-vs-Stage4 |
3.194400E-01 |
| Stage2-vs-Stage3 |
3.639600E-01 |
| Stage2-vs-Stage4 |
7.215800E-01 |
| Stage3-vs-Stage4 |
3.247800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.50879991728448E-10 |
| Normal-vs-AfricanAmerican |
2.18239999999481E-05 |
| Normal-vs-Asian |
4.177400E-01 |
| Caucasian-vs-AfricanAmerican |
4.901800E-02 |
| Caucasian-vs-Asian |
5.068200E-01 |
| AfricanAmerican-vs-Asian |
7.477600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.1188000526019E-09 |
| Normal-vs-Female |
1.29820000005498E-06 |
| Male-vs-Female |
3.469400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.3052000003011E-07 |
| Normal-vs-Extreme_Weight |
1.25720001076246E-09 |
| Normal-vs-Obese |
1.810680E-04 |
| Normal-vs-Extreme_Obese |
3.290200E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.236400E-01 |
| Normal_Weight-vs-Obese |
1.288990E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.726580E-01 |
| Extreme_Weight-vs-Obese |
1.994250E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.903620E-01 |
| Obese-vs-Extreme_Obese |
7.032600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.464900E-03 |
| Normal-vs-Age(41-60Yrs) |
3.3536999843875E-09 |
| Normal-vs-Age(61-80Yrs) |
4.01940000172019E-08 |
| Normal-vs-Age(81-100Yrs) |
4.010000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.227600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.317600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.973000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.107000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.715400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.781800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.08877359852977E-12 |
| Normal-VS-Type2 PRCC |
8.07369999999974E-05 |
| Normal-VS-KIRP CIMP |
6.260400E-01 |
| Normal-VS-Unclassified PRCC |
1.59770000007775E-07 |
| Type1 PRCC-VS-Type2 PRCC |
4.975600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.037900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.571800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.780000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.545790E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.126100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.95439999967273E-07 |
| Normal-vs-N1 |
3.642800E-03 |
| Normal-vs-N2 |
4.773100E-04 |
| N0-vs-N1 |
2.375400E-01 |
| N0-vs-N2 |
1.756990E-01 |
| N1-vs-N2 |
1.171190E-01 |
|
|
